Checkpoint Therapeutics I...

4.04
0.00 (0.00%)
At close: Apr 03, 2025, 3:59 PM
4.03
-0.12%
After-hours: Apr 03, 2025, 04:39 PM EDT

Checkpoint Therapeutics Statistics

Share Statistics

Checkpoint Therapeutics has 83.06M shares outstanding. The number of shares has increased by 33.15% in one year.

Shares Outstanding 83.06M
Shares Change (YoY) 33.15%
Shares Change (QoQ) 0%
Owned by Institutions (%) 5.63%
Shares Floating 62M
Failed to Deliver (FTD) Shares 5.49K
FTD / Avg. Volume 0.23%

Short Selling Information

The latest short interest is 5.56M, so 11.56% of the outstanding shares have been sold short.

Short Interest 5.56M
Short % of Shares Out 11.56%
Short % of Float 14.7%
Short Ratio (days to cover) 5.7

Valuation Ratios

The PE ratio is -2.26 and the forward PE ratio is 10.7. Checkpoint Therapeutics's PEG ratio is 0.05.

PE Ratio -2.26
Forward PE 10.7
PS Ratio 0
Forward PS 0.7
PB Ratio -10.06
P/FCF Ratio -4.08
PEG Ratio 0.05
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Checkpoint Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.37, with a Debt / Equity ratio of 0.

Current Ratio 0.37
Quick Ratio 0.37
Debt / Equity 0
Debt / EBITDA 0
Debt / FCF 0
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-2.45M
Employee Count 23
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 110.94% in the last 52 weeks. The beta is 1.42, so Checkpoint Therapeutics's price volatility has been higher than the market average.

Beta 1.42
52-Week Price Change 110.94%
50-Day Moving Average 3.37
200-Day Moving Average 2.96
Relative Strength Index (RSI) 65.92
Average Volume (20 Days) 2.43M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -56.17M
Net Income -56.24M
EBITDA -56.17M
EBIT n/a
Earnings Per Share (EPS) -1.42
Full Income Statement

Balance Sheet

The company has 6.6M in cash and 0 in debt, giving a net cash position of 6.6M.

Cash & Cash Equivalents 6.6M
Total Debt 0
Net Cash 6.6M
Retained Earnings -370.57M
Total Assets 5.18M
Working Capital -12.59M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -31.1M and capital expenditures 0, giving a free cash flow of -31.1M.

Operating Cash Flow -31.1M
Capital Expenditures 0
Free Cash Flow -31.1M
FCF Per Share -0.78
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CKPT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CKPT is $4.1, which is 1.2% higher than the current price. The consensus rating is "Hold".

Price Target $4.1
Price Target Difference 1.2%
Analyst Consensus Hold
Analyst Count 3
Stock Forecasts

Stock Splits

The last stock split was on Dec 6, 2022. It was a backward split with a ratio of 1:10.

Last Split Date Dec 6, 2022
Split Type backward
Split Ratio 1:10

Scores

Altman Z-Score -112.66
Piotroski F-Score 3